Suppr超能文献

一种新型非泡性手术即穿透性房角成形术治疗皮质类固醇性青光眼:一项前瞻性病例系列研究。

A new bleb-independent surgery namely penetrating canaloplasty for corticosteroid-induced glaucoma: a prospective case series.

作者信息

Hu Jing-Jing, Lin Hai-Shuang, Zhang Shao-Dan, Ye Wen-Qing, Gu Juan, Xie Yan-Qian, Tang Yi-Hua, Liang Yuan-Bo

机构信息

The Eye Hospital, School of Ophthalmology & Optometry, Wenzhou Medical University, Wenzhou 325027, Zhejiang Province, China.

Glaucoma Institute, Wenzhou Medical University, Wenzhou 325027, Zhejiang Province, China.

出版信息

Int J Ophthalmol. 2022 Jul 18;15(7):1077-1081. doi: 10.18240/ijo.2022.07.06. eCollection 2022.

Abstract

AIM

To report the outcomes of penetrating canaloplasty for corticosteroid-induced glaucoma in a case series.

METHODS

Penetrating canaloplasty is a bleb-independent filtering surgery unifying canaloplasty and trabeculectomy. In this study, the surgery was performed to restore the natural outflow through surgically expanded Schlemm's canal and generated trabeculum ostium. A total of 10 eyes of 8 patients were treated with penetrating canaloplasty for corticosteroid-induced glaucoma. Intraocular pressure (IOP) and the number of glaucoma medications at postoperative 3, 6, 12, 18, 24, 36, and 48mo were documented as primary endpoint. Complications after the surgery were recorded as secondary endpoint.

RESULTS

Penetrating canaloplasty was accomplished successfully for all 10 eyes, with a mean follow-up of 20.4±13.0mo (range 6-48mo). The mean preoperative IOP and number of anti-glaucoma medications were 45.1±6.5 mm Hg and 3.3±0.5 respectively. The mean post-operative IOP at 3, 6, 12, 18, 24, 36, and 48mo were 15.8±6.0, 14.7±3.3, 15.3±2.0, 15.6±2.6, 17.5±1.8, 16.5±4.9, and 14.0 mm Hg. The number of anti-glaucoma medications at these time points were all 0. This surgery failed to control the IOP in 1 eye at 1mo after surgery. Hyphaema occurred in 3 eyes on the first day after surgery. Postoperative transient IOP increasing was encountered with in two eyes from 1wk to 1mo after surgery. Choroidal detachment developed in one eye but responded well to conservative treatment.

CONCLUSION

Penetrating canaloplasty is effective for corticosteroid-induced glaucoma without serious complications, making it a viable or preferred alternative option.

摘要

目的

报告穿透性房角成形术治疗激素性青光眼系列病例的结果。

方法

穿透性房角成形术是一种不依赖于滤过泡的滤过性手术,它结合了房角成形术和小梁切除术。在本研究中,该手术通过手术扩张施莱姆管并形成小梁开口来恢复自然房水流出。共有8例患者的10只眼睛接受了穿透性房角成形术治疗激素性青光眼。记录术后3、6、12、18、24、36和48个月时的眼压(IOP)和青光眼药物使用数量作为主要终点指标。记录手术并发症作为次要终点指标。

结果

10只眼睛的穿透性房角成形术均成功完成,平均随访时间为20.4±13.0个月(范围6 - 48个月)。术前平均眼压和抗青光眼药物使用数量分别为45.1±6.5 mmHg和3.3±0.5。术后3、6、12、18、24、36和48个月时的平均眼压分别为15.8±6.0、14.7±3.3、15.3±2.0、15.6±2.6、17.5±1.8、16.5±4.9和14.0 mmHg。这些时间点的抗青光眼药物使用数量均为0。术后1个月时1只眼睛手术未能控制眼压。术后第1天有3只眼睛发生前房积血。术后1周内至1个月有2只眼睛出现短暂性眼压升高。1只眼睛发生脉络膜脱离,但保守治疗效果良好。

结论

穿透性房角成形术治疗激素性青光眼有效且无严重并发症,是一种可行或优选的替代选择。

相似文献

1
A new bleb-independent surgery namely penetrating canaloplasty for corticosteroid-induced glaucoma: a prospective case series.
Int J Ophthalmol. 2022 Jul 18;15(7):1077-1081. doi: 10.18240/ijo.2022.07.06. eCollection 2022.
2
[Preliminary efficacy of penetrating canaloplasty in primary angle-closure glaucoma].
Zhonghua Yan Ke Za Zhi. 2019 Jun 11;55(6):448-453. doi: 10.3760/cma.j.issn.0412-4081.2019.06.008.
3
Efficacy of bleb-independent penetrating canaloplasty in primary angle-closure glaucoma: one-year results.
Acta Ophthalmol. 2022 Feb;100(1):e213-e220. doi: 10.1111/aos.14869. Epub 2021 Apr 20.
5
Clinical outcomes of penetrating canaloplasty in patients with traumatic angle recession glaucoma: a prospective interventional case series.
Br J Ophthalmol. 2023 Aug;107(8):1092-1097. doi: 10.1136/bjophthalmol-2021-320659. Epub 2022 Mar 22.
7
Outcomes of Penetrating Canaloplasty in Childhood Glaucoma.
J Glaucoma. 2023 Jan 1;32(1):34-39. doi: 10.1097/IJG.0000000000002111. Epub 2022 Aug 19.
8
[Trabeculectomy versus canaloplasty].
Ophthalmologe. 2015 Apr;112(4):325-31. doi: 10.1007/s00347-014-3160-7.
9
New suture probe canaloplasty combined with suprachoroidal collagen implantation.
Int Ophthalmol. 2024 Apr 29;44(1):208. doi: 10.1007/s10792-024-03135-4.
10
Canaloplasty in Corticosteroid-Induced Glaucoma. Preliminary Results.
J Clin Med. 2018 Feb 11;7(2):31. doi: 10.3390/jcm7020031.

引用本文的文献

1
Five-year outcomes of trabeculo-canalectomy for Chinese PACG patients: a retrospective study.
BMC Ophthalmol. 2025 Apr 22;25(1):234. doi: 10.1186/s12886-025-04051-6.
2
Canaloplasty via an ab-interno surgical technique in patients with primary angle closure glaucoma.
Int Ophthalmol. 2024 Oct 4;44(1):401. doi: 10.1007/s10792-024-03322-3.
3
Historical and Contemporary Debates in Schlemm's Canal-Based MIGS.
J Clin Med. 2024 Aug 19;13(16):4882. doi: 10.3390/jcm13164882.
4
Penetrating canaloplasty in corticosteroid-induced glaucoma: a report of two cases.
Int J Ophthalmol. 2024 Apr 18;17(4):770-772. doi: 10.18240/ijo.2024.04.23. eCollection 2024.
7
Trend of glaucoma internal filtration surgeries in a tertiary hospital in China.
Int J Ophthalmol. 2023 Feb 18;16(2):251-259. doi: 10.18240/ijo.2023.02.12. eCollection 2023.

本文引用的文献

1
Clinical outcomes of penetrating canaloplasty in patients with traumatic angle recession glaucoma: a prospective interventional case series.
Br J Ophthalmol. 2023 Aug;107(8):1092-1097. doi: 10.1136/bjophthalmol-2021-320659. Epub 2022 Mar 22.
2
Efficacy of bleb-independent penetrating canaloplasty in primary angle-closure glaucoma: one-year results.
Acta Ophthalmol. 2022 Feb;100(1):e213-e220. doi: 10.1111/aos.14869. Epub 2021 Apr 20.
3
Kahook Dual Blade goniotomy in post penetrating keratoplasty steroid-induced ocular hypertension.
Am J Ophthalmol Case Rep. 2020 Jul 9;19:100826. doi: 10.1016/j.ajoc.2020.100826. eCollection 2020 Sep.
4
Improvement of the Safety Profile of Canaloplasty and Phacocanaloplasty: A Review of Complications and Their Management.
J Ophthalmol. 2020 Jun 16;2020:8352827. doi: 10.1155/2020/8352827. eCollection 2020.
5
Steroid-induced glaucoma: Epidemiology, pathophysiology, and clinical management.
Surv Ophthalmol. 2020 Jul-Aug;65(4):458-472. doi: 10.1016/j.survophthal.2020.01.002. Epub 2020 Feb 11.
7
[Preliminary efficacy of penetrating canaloplasty in primary angle-closure glaucoma].
Zhonghua Yan Ke Za Zhi. 2019 Jun 11;55(6):448-453. doi: 10.3760/cma.j.issn.0412-4081.2019.06.008.
8
The Genetic Influence on Corticosteroid-Induced Ocular Hypertension: A Field Positioned for Discovery.
Am J Ophthalmol. 2019 Jun;202:1-5. doi: 10.1016/j.ajo.2019.02.001. Epub 2019 Feb 11.
9
Canaloplasty in the Treatment of Open-Angle Glaucoma: A Review of Patient Selection and Outcomes.
Adv Ther. 2019 Jan;36(1):31-43. doi: 10.1007/s12325-018-0842-6. Epub 2018 Nov 28.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验